Role of microRNAs in stem/progenitor cells and cardiovascular repair

Cardiovascular Research

Volumn 93, Issue 4, 2012, Pages 614-622

  Jakob, Philipp ^a,b   Landmesser, Ulf ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cardiovascular repair; Endothelium; MicroRNA; Progenitor cell; Stem cell

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; DOWN REGULATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; INTIMA; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STEM CELL; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; MICRORNAS; STEM CELLS; TISSUE THERAPY;

EID: 84857927765     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr311     Document Type: Review

References (101)

1. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469:336-342.
2. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific microRNAs. Dev Cell 2003;5:351-358. (Pubitemid 37006477)
3. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 2008;453:223-227. (Pubitemid 351667975)
4. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455:1124-1128.
5. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009;137:647-658.
6. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011;8:376-388.
7. Judson RL, Babiarz JE, Venere M, Blelloch R. Embryonic stem cell-specific micro-RNAs promote induced pluripotency. Nat Biotechnol 2009;27:459-461.
8. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010;463:621-626.
9. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011;8:633-638.
10. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011;29:443-448.
11. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004;14:1902-1910. (Pubitemid 39386503)
12. Truscott M, Islam AB, Lopez-Bigas N, Frolov MV. mir-11 limits the proapoptotic function of its host gene, dE2f1. Genes Dev 2011;25:1820-1834.
13. Barik S. An intronic microRNA silences genes that are functionally antagonistic to its host gene. Nucleic Acids Res 2008;36:5232-5241.
14. Lutter D, Marr C, Krumsiek J, Lang EW, Theis FJ. Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. BMC Genomics 2010;11:224.
15. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-4060. (Pubitemid 39472426)
16. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-419. (Pubitemid 37187272)
17. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004;432: 235-240. (Pubitemid 39545855)
18. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of premicroRNAs and short hairpin RNAs. Genes Dev 2003;17:3011-3016. (Pubitemid 38040764)
19. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001;409:363-366. (Pubitemid 32151243)
20. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001;293:834-838. (Pubitemid 32743968)
21. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001;106:23-34. (Pubitemid 32709955)
22. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001;15:2654-2659. (Pubitemid 32988876)
23. Knight SW, Bass BL. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 2001;293:2269-2271. (Pubitemid 32900239)
24. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000;404: 293-296. (Pubitemid 30163547)
25. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001;293:1146-1150. (Pubitemid 32758097)
26. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005;433:769-773. (Pubitemid 40292988)
27. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-840.
28. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-1934.
29. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460: 705-710.
30. Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursors that bypass Drosha processing. Nature 2007;448:83-86. (Pubitemid 47037009)
31. Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 2007;130:89-100. (Pubitemid 47031325)
32. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010;465:584-589.
33. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010;328:1694-1698.
34. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003;35:215-217. (Pubitemid 37363172)
35. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T et al. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 2005;19:489-501. (Pubitemid 40256280)
36. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for micro-RNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007; 39:380-385. (Pubitemid 46328490)
37. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008;40:1478-1483.
38. Lichner Z, Pall E, Kerekes A, Pallinger E, Maraghechi P, Bosze Z et al. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. Differentiation 2011;81:11-24.
39. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
40. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
41. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
42. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3:595-605.
43. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.
44. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010;30:1118-1126.
45. Wang Z,Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-189. (Pubitemid 38374315)
46. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009;16:1590-1598.
47. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009;119:2634-2647.
48. Albinsson S, Skoura A, Yu J, DiLorenzo A, Fernandez-Hernando C, Offermanns S et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 2011;6:e18869.
49. Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J et al. Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011;31:368-375.
50. Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie RP et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 2011;20:205-210.
51. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009;284:3728-3738.
52. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487.
53. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005;280: 9330-9335. (Pubitemid 40409626)
54. Otsuka M, Zheng M, Hayashi M, Lee JD, Yoshino O, Lin S et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest 2008;118:1944-1954. (Pubitemid 351632396)
55. Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008;105:14082-14087.
56. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101:59-68. (Pubitemid 47094624)
57. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent micro-RNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007;100:1164-1173. (Pubitemid 46684129)
58. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-284.
59. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al. The endothelialspecific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-271.
60. Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND. MicroRNAmediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010;464:1196-1200.
61. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated micro-RNAs modulate E2F1 expression. Nature 2005;435:839-843. (Pubitemid 40839736)
62. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-833. (Pubitemid 40839734)
63. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-1713.
64. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010;115:4944-4950.
65. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38:1060-1065. (Pubitemid 44325933)
66. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-220. (Pubitemid 41021266)
67. Kwon C, Han Z, Olson EN, Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci USA 2005;102: 18986-18991. (Pubitemid 43049553)
68. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci USA 2006;103: 8721-8726. (Pubitemid 43878086)
69. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of micro-RNAs 1 and 133. Proc Natl Acad Sci USA 2007;104:20844-20849.
70. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-233. (Pubitemid 43177239)
71. Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008;2: 219-229. (Pubitemid 351298595)
72. Lu J, McKinsey TA, Zhang CL, Olson EN. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 2000;6:233-244.
73. King IN, Qian L, Liang J, Huang Y, Shieh JT, Kwon C et al. A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity. Dev Cell 2011; 20:497-510.
74. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007;129:303-317. (Pubitemid 46574975)
75. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008;22:3242-3254.
76. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222. (Pubitemid 351508308)
77. Li N, Wei C, Olena AF, Patton JG. Regulation of endoderm formation and left-right asymmetry by miR-92 during early zebrafish development. Development 2011;138: 1817-1826.
78. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA et al. MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010;30:859-868.
79. Hosoda T, Zheng H, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogorek B et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 2011;123:1287-1296.
80. Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 2010;3:426-435.
81. Shieh JT, Huang Y, Gilmore J, Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011;6:e19481.
82. Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res 2011;109:334-347.
83. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31:367-373. (Pubitemid 350127777)
84. Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, Xu Q et al. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21- dependent mechanism. Circ Res 2010;107:138-143.
85. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107: 677-684.
86. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011;124:175-184.
87. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M et al. Plasma micro-RNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817.
88. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
89. Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T et al. Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 2009;39:359-367.
90. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 2010;30:1562-1568.
91. Doerries C, Briand S, Besler C, Mocharla P, Mueller M, Manes C et al. Antimir treatment reveals a critical role of miR-126 and miR-130a for in vivo cardiac and endothelial repair capacity of early endothelial progenitor cells: marked down-regulation in patients with ischemic cardiomyopathy. Circulation 2010;122:A21339.
92. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008;111:1217-1226. (Pubitemid 351213403)
93. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 2009;13:1577-1585.
94. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421-13426.
95. Zhao T, Li J, Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 2010;299:E110-E116.
96. Haider KH, Idris NM, Kim HW, Ahmed RP, Shujia J, Ashraf M. MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 2010;88:168-178.
97. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-439.
98. Suzuki Y, Kim HW, Ashraf M, Haider H. Diazoxide potentiates mesenchymal stem cell survival via NF-kB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol 2010;299:H1077-H1082.
99. Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 2011;15:1474-1482.
100. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009;284:33161-33168.
101. Hu S, Huang M, Nguyen PK, Gong Y, Li Z, Jia F et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 2011;124:S27-S34.